• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

NPFFR1 Polyklonaler Antikörper

NPFFR1 Polyklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Ratte

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 23415-1-PBS

Synonyme

G protein coupled receptor 147, GPR147, neuropeptide FF receptor 1, OT7T022

Filter:
  • Western Blot (WB) analysis of various lysates using NPFFR1 Polyclonal antibody (23415-1-AP)

    WB analysis using 23415-1-AP (same clone as 23415-1-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 23415-1-AP (NPFFR1 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 23415-1-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

23415-1-PBS bindet in WB, Indirect ELISA NPFFR1 und zeigt Reaktivität mit human, Ratten

Getestete Reaktivität human, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen NPFFR1 fusion protein Ag20057
Vollständiger Name neuropeptide FF receptor 1
Berechnetes Molekulargewicht 430 aa, 48 kDa
Beobachtetes Molekulargewicht48-50 kDa
GenBank-ZugangsnummerBC131580
Gene symbol NPFFR1
Gene ID (NCBI) 64106
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-affinitätsgereinigt
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

NPFFR1 (Neuropeptide FF Receptor 1) is primarily focused on its role in various physiological and pathological processes. NPFFR1 is involved in modulating the effects of opioids, including their analgesic properties and side effects. This interaction has led to research into the potential use of NPFFR1 ligands to enhance opioid efficacy and reduce adverse effects (PMID: 32673481). Research suggests that NPFFR1 may have neuroprotective effects, particularly in the context of stroke recovery. It may promote neuronal survival, axonal growth, and reduce inflammation (PMID: 39519132).